Burden of Invasive Group B Streptococcal (GBS) Disease in Young Infants in China

Clinical trial NCT01933646 · COMPLETED

Trial details

NCT number: NCT01933646
Sponsor: Novartis Vaccines
Status: COMPLETED
Study type: OBSERVATIONAL

Invasive Group B Streptococcal Disease

Start date: 2013-09-01
Primary completion: 2014-09-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.